KROS icon

Keros Therapeutics

83 hedge funds and large institutions have $887M invested in Keros Therapeutics in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 13 closing their positions.

Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
1.46%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
15
Increased
31
Reduced
24
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Morgan Stanley
76
Morgan Stanley
New York
$18K 287 -75,348 -100%
Macquarie Group
77
Macquarie Group
Australia
$15K 250 +250 New
CSS
78
Cubist Systematic Strategies
Connecticut
$6K 100 -100 -50%
TIM
79
Tortoise Investment Management
New York
$6K 93 +93 New
ADIM
80
Alpha DNA Investment Management
Maryland
$4K 70 +27 +63%
Daiwa Securities Group
81
Daiwa Securities Group
Japan
$3K 44
TWA
82
TCI Wealth Advisors
Arizona
$2K 30 +30 New
AIG
83
American International Group
New York
$476 7,731 +150 +2%
RCM
84
RA Capital Management
Massachusetts
-1,875,000 Closed
LGM
85
Logos Global Management
California
-450,000 Closed
CCM
86
CAAS Capital Management
New York
-91,296 Closed
Federated Hermes
87
Federated Hermes
Pennsylvania
-47,703 Closed
APM
88
Avidity Partners Management
Texas
-40,000 Closed
Renaissance Technologies
89
Renaissance Technologies
New York
-10,100 Closed
Squarepoint
90
Squarepoint
New York
-9,035 Closed
PCM
91
Pinz Capital Management
New York
-8,099 Closed
AC
92
Athanor Capital
New York
-7,547 Closed
Susquehanna International Group
93
Susquehanna International Group
Pennsylvania
-6,398 Closed
PVI
94
Pura Vida Investments
New York
-5,000 Closed
Principal Financial Group
95
Principal Financial Group
Iowa
-3,140 Closed
PAM
96
Panagora Asset Management
Massachusetts
-14 Closed
CFGS
97
Concourse Financial Group Securities
Alabama